1 January 2017 - The January 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect.

The new calendar year sees some new and revised listings:

• Obinutzumab (Gazyva) - new listing
• Pertuzumab (Perjeta) - new listing
  
• Pirfenidone (Esbriet) - new listing
  
• Dornase alfa (Pulmozyme) - restriction change
  
• Rituximab (MabThera) - new indications
  
• Human papilloma virus vaccine (9 valent) (Gardasil 9) - new formulation
  

Read New Zealand Pharmaceutical Schedule update